After a short spell of good results, again we're getting way short reads on our 454 Titanium WGS runs. Last time this was down to dodgy consumables and Roche put a release out admitting there was a QC problem. Anyone else having problems recently?
-
-
Yes, but not very consistent so this could be due to sample problems. -
Same for us, we've had 5-6 runs of very short reads (250bp average) in the past 3 weeks after 3-4 months of 400+bp (many samples had previously been successfully sequenced so not sample related)Comment
-
Ah.
Perhaps it would be useful to compare lot numbers on consumables, do you have them to hand?Comment
-
Since we started using Seq kit 93801620 (for which they announced a new formulation of their substrate solution) although correlation is not perfect.Comment
-
The engineer came:
It seems some of the tubes inside were dirty and wash flow may have been insufficient which means removal of residual dNTP after each cycle would be incomplete and so as the reads progress, there is increasing corruption of the read sequence due to overlapping reads after displacement of the end of the strand 'forwards' by illegitimate insertion of bases that should not be available in the next cycle (if I've understood correctly), a phenomenon called read-forward. Apparently Roche's analysis of the data suggested that this was indeed the problem.
This suggests to us we need to make sure the tubes are replaced at no more than 12 mo intervals and possibly as little as 6 mo.
(Edited this post for clarity)Last edited by nickloman; 11-17-2010, 06:39 AM.Comment
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment